NCT05091658

Brief Summary

This study will assess the ability of the lay user to obtain and record a result. Comprehension of the instructions for use of the product will also be assessed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 12, 2021

Completed
2 days until next milestone

Study Start

First participant enrolled

October 14, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 25, 2021

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 10, 2021

Completed
Last Updated

November 24, 2021

Status Verified

November 1, 2021

Enrollment Period

27 days

First QC Date

October 12, 2021

Last Update Submit

November 23, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Lay user usage

    Ability of the lay user to perform a test and record their result

    1 hour

Secondary Outcomes (1)

  • Comprehension of instructions for use

    1 hour

Other Outcomes (1)

  • Lay user ability to read a high and a low result

    1 hour

Interventions

Test for qualitative detection of LH in urine

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemales are representative of the intended user of the product
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women between the ages of 18 to 45 represent the intended user of the product

You may qualify if:

  • Female
  • Aged 18 to 45 years
  • Willing to give informed consent and comply with the investigational procedures

You may not qualify if:

  • Used Clearblue® me Period Tracker app Persona or FAM within the last six months
  • Currently or previously employed by SPD, Abbott, Alere, Unipath, P\&G or affiliates
  • Has an immediate\* relative currently or previously (within past 5 years) employed by SPD, Abbott, Alere, Unipath or P\&G, or affiliates
  • Is a qualified or trainee healthcare professional (HCP)
  • Has professional experience of using dipstick type tests or lateral flow devices
  • Currently breastfeeding, pregnant or seeking to conceive
  • Currently menstruating∆ \*Immediate relatives are defined as parents, children, siblings or partner/spouse ∆Volunteer can start the study when their period has ended.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SPD Development Company Ltd

Bedford, Bedfordshire, MK44 3UP, United Kingdom

Location

Study Officials

  • Sharon Bond

    SPD Development Company

    PRINCIPAL INVESTIGATOR
  • Raniero Zazzeroni

    SPD Development Company

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 12, 2021

First Posted

October 25, 2021

Study Start

October 14, 2021

Primary Completion

November 10, 2021

Study Completion

November 10, 2021

Last Updated

November 24, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

No plan to share individual participant data

Locations